Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma
Chiara De Philippis, Daniele Mannina, Laura Giordano, Elena Costantini, Simona Marcheselli, Jacopo Mariotti, Barbara Sarina, Daniela Taurino, Armando Santoro, Stéfania Bramanti
Topics & Concepts
TocilizumabMedicineCytokine release syndromeChimeric antigen receptorInternal medicineAdverse effectLymphomaImmunotherapyCancerDiseaseCAR-T cell therapy research